Back to search

University of Crete (UOC)

Διερεύνηση λειτουργικότητας της ογκοκατασταλτικής οδού του p53 στο αναπλαστικό λέμφωμα από μεγάλα κύτταρα ALK-αρνητικό

Abstract

dc:description

Systemic anaplastic large cell lymphoma (ALCL) without anaplastic lymphoma kinase (ALK) positivity, was recognized as a distinct disease entity in the World Health Organization's lymphoma classification in 2016 (ALK-ALCL).Multiple studies have shown its similarities and differences from systemic ALK positive ALCL, as well as from peripheral T cell lymphoma not otherwise specified (PTCL-NOS), at epidemiological, pathogenetic and therapeutic level. In contrast to ALK+ ALCL, the prognosis of ALK- ALCL is overall worse with existing therapeutic regimens, characterized by short periods of remission and disease control, typically followed by relapses with extremely poor prognosis. Therefore, discovering new treatment strategies is urgently needed. ALK- ALCL shows pathogenetic similarities to ALK + ALCL with deregulation of T cell receptor and CD30 receptor signaling pathways, as well as aberrations in JAK-STAT, PI3K-Akt-Sonic Hedgehog, MAPK-mTOR-AP1 and NF-kB signalingpathways. Abnormalities of the cytoskeleton and modification of the host’s immune response are responsible for its morphological characteristics and aggressive clinical course. ALK-ALCL is characterized by the presence of chromosomal translocations and abnormal karyotype, as well as the presence of chimeric proteins, point mutations and expression of abnormal gene transcripts. Numerous studies have highlighted the role of the p53 signaling pathway as a key regulator of cell cycle, cell’s survival, genetic repair, senescence and death, and revealed the dual role of the p53 gene as a tumor suppressor gene and potential oncogene in multicellular organisms. The role of the p53 signaling pathway, in maturation, differentiation, activation, apoptosis, and clonal T cell expansion, as well as its implication in the immune response, autoimmunity, and lymphomatogenesis, has also been investigated. p53 protein levels are mainly regulated by its interaction, with the E3 ligases MDM2 and MDMX, which modify p53 post-translationally, leading to its degradation in the proteasome. In a significant number of cases, ALCLs carry the non-mutated p53 (wt p53) protein, but the corresponding signaling pathway is inactive. In both ALK + and ALK-ALCL, reactivation of the p53 signaling pathway is possible, using small inhibitors of the MDM2 molecule. Inhibition of MDM2, caused variable inhibition of cell proliferation and apoptosis in ALCL cell lines, indicating the presence of other p53 signaling repression mechanisms. Data indicating that MDMX protein, a negative regulator of the p53 signaling pathway, is involved in inactivating p53 signaling in ALCL are presented in this dissertation. Western blot analysis showed that MDMX protein is overexpressed in ALK+ ALCL cell lines and shows varied expression in ALK-ALCL cell lines. Immunohistochemical analysis for MDMX protein in biopsy material from patients with ALK+ ALCL and ALK-ALCL showed increased expression of MDMX in 78% of patients with ALK+ ALCL and in 41% of patients with ALK-ALCL (p <0.0018 Mann Whitney test). In situ fluorescent hybridization (FISH) analysis, showed profound amplification of the MDMX gene in 8% (1/13) of patients with ALK- ALCL as well as low levels of multiple copies of the MDMX gene in 15% (2/13) of patients with ALK-ALCL and in 27% (3/11) of patients with ALK+ ALCL.Pharmaceutical inhibition of MDMX, as well as silencing of the MDMX gene using siRNA, were associated with reactivation of the p53 signaling pathway, cell cycle arrest, and apoptotic cell death in ALK+ and ALK- ALCL cell lines with wtp53. These findings provide evidence that MDMX targeting may be a new therapeutic approach for ALCL patients with wtp53 tumors.

Degree

thesis:*
Grantor dc:publisher
University of Crete (UOC)
Year dc:date
2021

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Sinatkas, Vaios
  • Σινάτκας, Βάιος

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/49692

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Sinatkas, Vaios; Σινάτκας, Βάιος. Διερεύνηση λειτουργικότητας της ογκοκατασταλτικής οδού του p53 στο αναπλαστικό λέμφωμα από μεγάλα κύτταρα ALK-αρνητικό. University of Crete (UOC), 2021. http://hdl.handle.net/10442/hedi/49692